bioAffinity Technologies(us:BIAF)
0.9928
-15.86%
Updated on 2024-12-22
Open:1.24
Close:0.9928
High:1.29
Low:0.9820
Pre Close:1.18
Volume:478853.00
Amount:514108.34
Turnover:3.07%
Shares:15.58M
MarketCap:15.47M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 19 | 399694 | 3.48% | 5 | 7 | 3 |
| 2024-03-31 | 15 | 234689 | 2.09% | 4 | 5 | 3 |
| 2023-12-31 | 13 | 156046 | 1.66% | 3 | 2 | 3 |
| 2023-09-30 | 10 | 119176 | 1.29% | 3 | 2 | 2 |
| 2023-06-30 | 7 | 96694 | 1.13% | 1 | 1 | 2 |
| 2023-03-31 | 8 | 102367 | 1.21% | 3 | 1 | 3 |
| 2022-12-31 | 9 | 83455 | 1.00% | 3 | 1 | 5 |
| 2022-09-30 | 6 | 66081 | 0.79% | 6 | 0 | 0 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Vanguard Group Inc | 70326 | 0.63% | 50326 | 251.63% |
| 2024-03-31 | Geode Capital Management, Llc | 42078 | 0.38% | 5309 | 14.44% |
| 2024-03-31 | Renaissance Technologies Llc | 37500 | 0.33% | 37500 | |
| 2024-03-31 | Captrust Financial Advisors | 27885 | 0.25% | -12000 | -30.09% |
| 2024-03-31 | State Street Corp | 17600 | 0.16% | 0 | |
| 2024-03-31 | Northern Trust Corp | 13662 | 0.12% | 13662 | |
| 2024-03-31 | Creative Planning | 12095 | 0.11% | 0 | |
| 2024-03-31 | Sheaff Brock Investment Advisors, Llc | 10000 | 0.09% | 10000 | |
| 2024-03-31 | Tower Research Capital Llc (Trc) | 3347 | 0.03% | 386 | 13.04% |
| 2024-03-31 | Clear Street Llc | 100 | 0.00% | 100 |
About
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.
Address:22211 West Interstate 10,Suite 1206
Website:http://www.bioaffinitytech.com
Market Movers